Olivia Friett, editor of Medical Plastics News, speaks to David Regan, CEO of Sona Nanotech and Darcy Hart, Optics Engineering Director from Minnetronix Medical to discuss Sona’s Targeted Hyperthermia Therapy (THT) using gold nano rods, and how it differs from other therapies used to treat cancer.
© Rapid Medtech Communications Ltd. A Rapid News Group Company. All Rights Reserved.
Built with Metro Publisher™